Effects of Progesterone on Vasomotor Symptoms in Postmenopausal Women (PROGEST) - a Prospective Multi-Center Randomized Double-Blind Placebo-Controlled Trial (RDPCT).

Geburtshilfe Frauenheilkd · 2024 · PMC11444746 · PMID 39359545

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Therefore, no validated conclusion can be drawn, but a positive trend for elevating progesterone daily dose appeared to lead to decreasing VMS in postmenopausal women.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.